NHMRC Glaucoma Guidelines - ANZGIG

More documents

Recommendations

Info

NHMRC GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA Guideline development details ■ Guideline development details Purpose This guideline presents the current best evidence for screening, prognosis, diagnosis, management and prevention of glaucoma. Its purpose is to inform practice for Australian health care providers, particularly utilising a multi-disciplinary team approach. Target users This guideline is primarily targeted to Australian primary health care providers undertaking any task related to screening, prognosis, diagnosis, management and prevention of glaucoma, in any setting. Information is also provided for secondary health care providers. Guideline development period The systematic review underpinning these guidelines was completed in September 2008. The guideline was developed between August 2008 and June 2009. Public consultation occurred during October and November 2009. Date of review Given the rapid advances in knowledge regarding aspects of screening, prognosis, diagnosis, management and prevention of glaucoma, it is recommended that the literature is revisited in 2011. Guideline development team Centre for Allied Health Evidence, University of South Australia (Technical Team) Professor Karen Grimmer-Somers Ms Judith Lowe Ms Anthea Worley Ms Janine Dizon Ms Lucylynn Lizarondo National Health and Medical Research Council Expert Working Committee Professor William Morgan (Ophthalmologist) Lions Eye Institute (CHAIR) Associate Professor Ivan Goldberg (Ophthalmologist) Eye Associates Glaucoma Services Sydney Eye Hospital Professor Jonathon Crowston (Ophthalmologist) Centre for Eye Research Australia Professor David Mackey (Epidemiologist/Ophthalmologist/Geneticist) Lions Eye Institute, Perth National Health and Medical Research Council 9
NHMRC GUIDELINES FOR THE SCREENING, PROGNOSIS, DIAGNOSIS, MANAGEMENT AND PREVENTION OF GLAUCOMA Guideline development details Professor Algis Vingrys (Optometrist) Department of Optometry and Visual Sciences University of Melbourne Dr Philip Anderton (Optometrist) Rural Dr Amanda McBride (General Practitioner with interest in Glaucoma) Miller St Medical Practices, North Sydney Dr Genevieve Napper (Optometrist, low vision service provider) Victorian College of Optometry Mr Grant Martin (Director, Professional Services) Pharmaceutical Society of Australia Ms Jill Grasso (Ophthalmic Nurse) Representing the Ophthalmic Nurses Association Ms Beverly Lindsell (Glaucoma Australia Representative) Glaucoma Australia Ms Tania Straga (Orthoptist) Representing the Australian Orthoptists Association Ms Helen Robbins (Observer) Representing the Optometrists Association Australia Internal reference group Mr Luke Grzeskowiak, Pharmacist University of South Australia NHMRC project staff Ms Vesna Cvjeticanin, Director, Evidence Translation Section NHMRC Ms Heather Bishop, Assistant Director, Evidence Translation Section NHMRC Ms Carla Rodeghiero, Senior Project Officer, Evidence Translation Section NHMRC (2007/2008) Mr Fethon Ileris, Senior Project Officer, Evidence Translation Section NHMRC (2008/2009) Ms Tess Winslade, Senior Project Officer, Evidence Translation Section NHMRC (2009/2010) Ms Marion Hewitt, Project Officer, Evidence Translation Section NHMRC (2010) Ms Kay Currie, Director, (National Institute for Clinical Studies (NICS) NHMRC) Conflict of interest Members were required to submit any conflict of interests to NHMRC. One member identified a conflict of interest that was considered by NHMRC and deemed not to affect their membership or voting entitlement. Funding This guideline was commissioned by NHMRC and funded by the Department of Health and Ageing. The Expert Working Committee members received no remuneration for their involvement in the development of the guideline. Process report The process report for this guideline is provided in Appendix 1. 10 National Health and Medical Research Council
Page 1: NHMRC Guidelines for the Screening,
Page 4 and 5: NHMRC GUIDELINES FOR THE SCREENING,
Page 8: NHMRC GUIDELINES FOR THE SCREENING,
Page 65 and 66:
NHMRC GUIDELINES FOR THE SCREENING,
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139:
Page 140 and 141:
Page 142 and 143:
Page 144:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 172 and 173:
Page 174:
Page 177 and 178:
Page 179 and 180:
Page 181:
show all

NHMRC Glaucoma Guidelines - ANZGIG

Create successful ePaper yourself

Delete template?

Save as template?